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ABSTRACT
Introduction: Rotavirus infection is a leading place in the structure of acute intestinal infections in children. Rotavirus is excreted in 4 0-60  %  of children hospitalized with 
gastroenteritis all over the world. Every year, 2 million patients are hospitalized with a severe form of RVI, 25 million need medical help from a doctor and 111 million cases 
are treated at home.
The aim: The purpose of our study was to optimize the treatment of rotavirus infection in children by using Bacillus clausii.
Materials and methods: There were 65 children with a rotavirus infection under supervision. The control group was consisted of 28 practically healthy children. The study of 
humoral immunity was carried out on the basis of determining the serum content of immunoglobulin G, immunoglobulin M, immunoglobulin A, and secretory immunoglobulin 
A in coprofiltrate. In the process of treatment, the children were divided into two groups: the first received standard treatment, the second group were added to standard 
treatment with a probiotic drug (Bacillus clausii).
Results: In children with RVI with modified treatment main symptoms were reduced compared with the children receiving standard treatment, (p <0.001). In patients with 
rotavirus infection in the acute period of the disease, a decrease in the concentration of IgA (p <  0.001) and an increase in IgM (p <  0.001) in serum and a decrease in sIgA 
(p <  0.001) in coprofiltrate was observed in comparison with children in control group. In the period of reconvalescence in children after the traditional treatment, it wasn't 
revealed normalization of the immunoglobulins. Patients receiving a probiotic drug in addition to traditional treatment it was revealed normalization of the parameters of 
serum immunoglobulins A, M, G and sIgA in coprofiltrate.
Conclusions: So, the probiotic drug containing Bacillus clausii has a positive effect on the humoral immune system in children with rotavirus infection.
KEYWORDS: rotavirus, humoral immunity, children, IgA, sIgA, IgM, IgG
INTRODUCTION
Rotavirus infection (RVI) is an urgent problem, because 
it is extremely widespread, especially among young chil­
dren, is characterized by the severity of the course and 
the frequency of adverse outcomes and consequences 
[1]. Rotavirus infection is a leading place in the structure 
of acute intestinal infections in children [2]. Rotavirus is 
excreted in 40 -6 0  % of children hospitalized with gastro­
enteritis all over the world. Every year, 2 million patients 
are hospitalized with a severe form of RVI, 25 million 
need medical help from a doctor and 111 million cases are 
treated at home [3, 4]. The most severe illness occurs in 
children at the age of 4-36 months life. Annually, rotavirus 
infection causes more than 600,000 deaths in children 
under the age of 5 who die from severe dehydration and 
electrolyte imbalance [5, 6]. Almost every young child is 
infected with rotavirus regardless of place of residence and 
socio-economic status [7].
Infection of the intestine with rotavirus depends on 
many factors: such as pH of the gastric juice, the presence 
of trypsin in the secretion of the duodenum, the level of
Wiad Lek 2019, 72, 7, 1320-1323
secretory IgA and the features of the morphology of the 
mucous membrane. The virus is tropical to the cells of the 
cylindrical epithelium, located on the villi of the duodenum 
and in the upper parts of the small intestine [8]. Protection 
of the human body from the rotavirus is ensured by the 
components of cellular and humoral immunity [9]. Anti­
bodies protect not only from the development of clinical 
manifestations of RVI, but also from infection. This protec­
tion depends on the level of antibodies: high-titers children 
are completely protected from rotavirus infection [10, 11]. 
These facts determine the need for effective therapeutic and 
prophylactic measures against rotavirus gastroenteritis.
THE AIM
The purpose of our study was to optimize the treatment 
of rotavirus infection in children by using Bacillus clausii.
MATERIALS AND METHODS
Under observation, there were 65 children with RVI from 
6 months to 5 years old (main group) who were treated at
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the Communal Nonprofit Enterprise “Children’s Clinical 
Hospital of St. Zinaida” of Sumy City Council.
All children were enrolled in the study after informed 
consent from their parents or guardians. Ethical approval 
was obtained from Institutional research ethics commit­
tees.
Criteria for inclusion:
• age from 6 months to 5 years;
• rotavirus infection;
• hospitalization in acute phase of the disease;
• informed consent from children’s parents or guardians;
• the absence of comorbidity in patients;
• children didn’t take drugs, which were contributed to 
the change in the amount of trace elements.
Criteria for exclusion:
• age less than 6 months, or more than 5 years;
• Acute intestinal infection of another viral or bacterial 
etiology, as well as mixed variants of rotavirus infection 
(with other viruses or bacteria).
• hospitalization in mild phase of the disease;
• parents or guardians of children didn’t give informed 
consent;
• presence of comorbidity in children.
Diagnosis of acute intestinal infection of rotavirus etiology 
was verified according to anamnesis, parent complaints, 
subjective and objective symptoms, and the results of the 
immuno-chromatographic test «CITO TEST ROTA» by 
Pharmaco Ltd. The control group consisted of 28 practically 
healthy children. The study was conducted during the acute 
period of the disease (for 1 -2 days) and during the reconva­
lescence period (5-6 days). During the study, the children of 
the main group were divided into two groups: the I group 
consisted of 34 children with RVI who received standard 
treatment (symptomatic therapy, sorbents, rehydration 
therapy), and the second group included 31 children with 
RVI who had received standard treatment A probiotic drug 
containing spores of the polysaccharide strain Bacillus 
clausii - 2 x 109 and purified water (1 vial 1 time per day) 
is added. The study of humoral immunity was based on 
the determination of the content of immunoglobulin G 
(Ig G), immunoglobulin M (Ig M) and immunoglobulin 
A (Ig A) by the method of radial immunodiffusion in agar 
for Mancini G [12]. The level of secretory immunoglob­
ulin A (sIg A) was determined in the excrements by the 
immune enzyme with the method using the «Vector Best» 
test systems (Novosibirsk, Russia). Statistical processing of 
the data was carried out by generally accepted methods of 
variation statistics. The following indicators were deter­
mined: arithmetic average (M), average error (m), level 
of differences between the two mean values (confidence 
probability - p). Calculations were made on a personal 
computer using Microsoft Excel programs adapted for 
medical and biological research.
RESULTS AND DISCUSSION
The main clinical symptoms in children with rotavirus 
infection were: hyperthermia, vomiting and diarrhea. At
an objective examination of children with RVI patients, 
reduced elasticity of the skin and turgor of soft tissues 
was revealed, which is a manifestation of exclusion due 
to the general dehydration of the organism. Children 
with RVI with deep palpation of the abdomen noted 
pain in the epigastrium and umbilical region, as well as 
rumbling along the intestinal tract. Moreover, clinical 
signs I and II had no significant differences (p > 0,05). 
In children with RVI with modified treatment, signs of 
general weakness disappeared by 1.17 days (p < 0.001) 
earlier than in children receiving standard therapy. For 
patients in this group, the duration of treatment was char­
acterized by a reduction in the duration of swelling and / 
or abdominal pain by 0.72 days (p < 0.05) compared with 
standard treatment children. In patients with modified 
treatment, the raised body temperature was shorter by
0. 52 days, compared with standard treatment (p < 0.05). 
In addition, patients in group II reduced the duration of 
diarrhea by 1.13 days (p < 0.001), and shortened vomiting 
by 0.6 days (p < 0.001) compared with children in group
1. Along with this, there was no significant difference 
between the I and II groups regarding the duration of 
clinical symptoms such as pallor of the skin and appetite 
disturbance (p > 0.05).
In the period of the onset of the disease in patients with 
rotavirus infection (the main group) it was observed a sig­
nificant reduction of IgA levels (0.58 ± 0.02) g / l compared 
to the similar indicator of children in the control group 
(0.82 ± 0.02) g / l (p < 0.001) (Table I). While the concen­
tration of IgM was (1.01 ± 0.02) g / l and was significantly 
higher than the similar indicator of the control group (0.73 
± 0.02) g / l (p < 0.001), and the IgG level (8,42 ± 0.18) g / 
l did not differ significantly from the children in the con­
trol group (7.96 ± 0.21) g / l (p > 0.05). The secretory IgA 
in coprofiltrate in patients with CVI decreased to (23.15 
± 0.42) mg / l in relation to the data of virtually healthy 
children (31.18 ± 0.63) mg / l (p < 0.001).
The period of reconvalescence in children of group I 
after the traditional treatment was characterized by an 
increase in IgA to (0.71 ± 0.02) g / l (p < 0.001) and IgG 
(9.32 ± 0.19) g / l (p < 0, 05). While the concentration of 
IgM before discharge from the hospital decreased and it 
was (1,03 ± 0,03) g / l (p > 0,05). The level of secretory IgA 
in coprofiltrate in sick children increased and amounted 
to (27.10 ± 0.31) mg / l (p < 0.001).
Patients in the 2nd group, who received a probiotic drug 
in addition to traditional treatment, showed normalization 
of serum immunoglobulin A, M, G, and secretory immu­
noglobulin A in coprofiltrate.
The results of many studies indicate a positive effect of 
probiotic drugs on the course of acute and persistent diar­
rhea [13, 14]. In the study, researchers point to a decrease 
in the duration of diarrhea in children with acute intestinal 
infections, which was additionally designated Bacillus 
clausii [15]. Currently, the most well documented probiotic 
bacteria used in human therapy are lactic acid bacteria. In 
contrast, studies aimed at studying the mechanisms respon­
sible for the probiotic positive effects of Bacillus are rare.
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Table I. Dynamics of indicators of humoral imm unity in children suffering from rotavirus infection, depending on the performed therapy, M ±  m
M ain g ro u p
Im m unological index
Control grou p  
(n=28) before treatm ent
after treatm ent
(n=65)
(n=65) 1 grou p
(n=34)
II grou p
(n=31)
1 2 3 4
0 ,5 8  ±  0 ,02 
P 1 2  <  0,001
0,71 ±  0 ,0 2
O, 86  ±  0 ,03
P ,  4 >  0,05 
P 2_4 <  0,001
Ig A , g  /  l 0 ,8 2  ±  0 ,0 2 P 1-3 <  0,001
p 2-3 <  0,001
P 3-4 <  0,001
Ig G , g  /  l 7 ,9 6  ±  0,21
8 ,4 2  ±  0 ,18 
p 1-2 >  0,05
9,3 2  ±  0 ,1 9  
P 1 3  <  0,001 
P 2_3 <  0 ,05
9,11 ±  0 ,2 2  
P ,_4 >  0,05 
P 2_4 >  0,05 
P 3-4 >  0,05
1,01 ±  0 ,02 
P 1 2  <  0,001
1,03 ±  0 ,03
O, 79  ±  0 ,03
P ,  4 >  0,05 
P 2_4 <  0,001
Ig M, g  /  l 0 ,73 ±  0 ,0 2 P 1-3 <  0,001 
P 2_3 >  0 ,05
P 3-4 <  0,001
2 7 ,1 0  ±  0,31 
P 1 3  <  0,001 
P 2 3  <  0,001
3 0 ,3 2  ±  0 ,39
s Ig  A , m g  /  l 3 1 ,1 8  ±  0,63
2 3 ,1 5  ±  0 ,4 2
p 1-2 <  0,001
P ,_4 >  0,05 
P 2_4 <  0,001 
P 3-4 <  0,001
Notes: p1-2-the reliability of the difference between the indicators of the primary group's children before treatment and the control group; p1-3 -  the 
reliability of the difference between the indicators of children in group I after treatment and control group; p2-3 - the reliability of the difference between 
the indicators of the children of the main group before treatment and Group I after treatment; p1-4 - the reliability of the difference between the indicators 
of children of group II after treatment and the control group; p2-4 - the reliability of the difference between the indicators of the children of the main 
group before treatment and the second group after treatment; p3-4 - the reliability of the difference between the indices of children of the 1st and 2nd 
groups after treatment.
In the work of Urdaci, M. C., Bressollier, Ph., Pinchuk,
I. (2004) evaluation of the immunomodulating properties 
of probiotic strains of B. clausii was performed in vitro on 
Swiss and C57 Bl / 6j mouse cells. The authors demonstrate 
that these strains in their vegetative forms are able to induce 
the activity of NOS II synthetase, IFN-y production and 
the proliferation of CD4 + T cells [16].
The results of our study showed a decrease in the concen­
tration of class A immunoglobulin and an increase in IgM 
in children with rotavirus infection, which may indicate the 
activation of the antibody formation in the acute period of the 
disease, against the background ofan increased local response to 
antigenic stimulation in the intestine. Decreased IgA concentra­
tions may be due to immaturity of the immune function of the 
intestine in young children and / or poor adhesion of the virus 
and neutralizing ability. At the same time, a slow “immunolog­
ical start” or transient hypogammonoglobulinemia in young 
children may explain insufficient IgG and IgA levels during 
the infectious process. During the treatment of children with 
rotavirus diarrhea in the acute period of the probiotic prepa­
ration containing Bacillus, there was a rapid positive dynamics 
of the course of the inflammatory process: the immunological 
parameters reached the level of children in the control group.
So, the probiotic drug containing Bacillus clausii has a 
positive effect on the humoral immune system in children 
with rotavirus infection.
According to the results of our study, it was found that in 
children with rotavirus infection a decrease in the level of 
immunoglobulin of class A and an increase in IgM was ob­
served. A low level of IgA during the infectious process may 
be due to immaturity of the immune function of the intestine 
in children or a slow “immunological start” in and / or poor 
adhesion of the virus and neutralizing ability. An increase in 
Ig M may indicate activation of the antibody formation in 
the acute period of the disease, against the backdrop of an in­
creased local response to antigenic stimulation in the intestine. 
When included in the treatment of children with rotavirus 
diarrhea in the acute period of the probiotic preparation con­
taining Bacillus clausii, there was a rapid positive dynamics of 
the course of the inflammatory process: reduction of clinical 
symptoms and normalization of immunological parameters.
Thus, the use in the complex treatment of rotavirus 
infection of a probiotic drug containing Bacillus clausii, 
contributed to improving the effectiveness of treatment.
CONCLUSIONS
1. The inclusion of Bacillus clausii in the treatment of chil­
dren with rotavirus infection contributed the reduction 
in the duration of clinical symptoms.
2. In children with rotavirus infection in the acute period 
of the disease, there was a decrease in the concentration
1322
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of IgA and an increase in the level of IgM in serum and 
a decrease in sIgA in coprofiltrate.
3. During the period of reconvalescence in children with 
rotavirus infection after standard treatment, the hu­
moral link of the immune system was characterized by 
improvement of the indicators, however, they did not 
reach the level of control group children.
4. In patients with rotavirus infection, which had been 
added to the traditional treatment with Bacillus clausii, 
the indices of the humoral immune system reached the 
level of control group children.
Prospects for further research: It will be perspective to 
further studying the effects of this probiotic drug on other 
parts of the immune system of children.
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